Lv33
240 积分 2021-12-21 加入
Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges
3小时前
待确认
Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design
5小时前
已完结
Drug-drug and drug-nutraceutical cocrystal/salt as alternative medicine for combination therapy: a crystal engineering approach
1天前
已完结
Formation of drug–drug salt crystals and co-amorphous forms of levofloxacin and 4-aminosalicylic acid for pulmonary applications
1天前
已完结
Enhanced NSAIDs Solubility in Drug–Drug Formulations with Ciprofloxacin
1天前
已完结
Pharmaceutical salts
1天前
已完结
An analysis of multidrug multicomponent crystals as tools for drug development
1天前
已完结
Pharmaceutical Salts: Comprehensive Insights From Fundamental Chemistry to FDA Approvals (2019–2023)
1天前
已完结
New drug-drug salts of palbociclib and nonsteroidal anti-inflammatory drugs with enhanced physicochemical properties and antitumor activities
1个月前
已完结
Insight on a novel drug-drug salt levofloxacin-flufenamate crystal structures, physicochemical properties, potency, and anti-inflammation improvement
1个月前
已关闭
皖公网安备34019202002308
